3-Bromocytisine is a derivative of the toxic alkaloid cytisine that acts as a highly potent agonist at neural nicotinic acetylcholine receptors, binding primarily to the ñ<sub>4</sub>ò<sub>2</sub> and ñ<sub>7</sub> subtypes. 3-Bromocytisine is a full agonist at the ñ<sub>7</sub> subtype while it is only a partial agonist at ñ<sub>4</sub>ò<sub>2</sub>, but has an extremely strong binding affinity at ñ<sub>4</sub>ò<sub>2</sub> with 200-fold selectivity for ñ<sub>4</sub>ò<sub>2</sub> over ñ<sub>7</sub>. In animal studies 3-bromocytisine stimulates the release of dopamine and noradrenaline and increases locomotor activity.